Jennifer. S. Gregory

Jennifer. S. Gregory

Auto-generated profile, based on publicly available information

Jennifer. S. Gregory

University of Aberdeen, Centre for Arthritis and Musculoskeletal Health, Aberdeen, United Kingdom

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2007 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
JGJennifer S. Gregory
Jennifer S. Gregory
JWJan H. Waarsing
Jan H. Waarsing
JDJudd Day
Judd Day
HPHuibert A. Pols
Huibert A. Pols
MRMax Reijman
Max Reijman
RARichard M. Aspden
Richard M. Aspden
Objective: Few methods exist to measure the progression of osteoarthritis (OA) or to identify people at high risk of developing OA. Striking radiographic changes include deformation of the femoral head and osteophyte growth, which are usually measured semiquantitatively following visual assessment. In this study, an active shape model (ASM) of the proximal femur was used to determine whether morphologic changes to the bone could be quantified and used as a marker of hip OA.Methods: One hundred ten subjects who had no signs of radiographic hip OA at baseline (Kellgren/Lawrence [K/L] scores 0–1) were selected from the Rotterdam Study cohort of subjects ages ≥55 years. To measure the progression of OA, subjects were followed up with radiographic assessment after 6 years. At the 6‐year followup, 55 subjects had established OA (K/L score 3), and in 12 of these OA subjects, the progression of the disease required a total hip replacement (THR). Age‐ and sex‐matched control subjects had a K/L score of 0 at followup. Using the ASM, subjects were assessed for shape changes in the femoral head and neck before, during, and after the development of radiographic OA. Scores of shape variance, or mode scores, were assigned for 10 modes of variation in each subject, and differences in mode scores were determined.Results: During followup, significant changes in shape of the proximal femur occurred within the OA group from baseline to followup (P < 0.0001 for mode 1 and P = 0.002 for mode 6) but not within the control group. At baseline (all subjects having K/L scores 0–1), there were significant differences in mode 6 between the OA group and the control group (P = 0.020), and in modes 3 and 6 between the OA subjects who underwent THR and the remaining OA subjects (P = 0.012 and P = 0.019, respectively).Conclusion: Compared with traditional scoring methods, the ASM can be used more precisely to quantify the deforming effect of OA on the proximal femur and to identify, at an earlier stage of disease, those subjects at highest risk of developing radiographic OA or needing a THR. The ASM may therefore be useful as an imaging biomarker in the assessment of patients with hip OA.

4 July 2016 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JNJérôme Nicod
Jérôme Nicod
RDRobert W Davies
Robert W Davies
NCNa Cai
Na Cai
CHCarl Hassett
Carl Hassett
LGLeo Goodstadt
Leo Goodstadt
JFJonathan Flint
Jonathan Flint
Jonathan Flint, Richard Mott and colleagues employ low-coverage (0.15×) sequencing and their new imputation method STITCH to perform genome-wide association analysis for complex traits in an outbred mouse population. They find >250 QTLs for 92 phenotypes and obtain gene-level mapping resolution for around 20% of the loci. Two bottlenecks impeding the genetic analysis of complex traits in rodents are access to mapping populations able to deliver gene-level mapping resolution and the need for population-specific genotyping arrays and haplotype reference panels. Here we combine low-coverage (0.15×) sequencing with a new method to impute the ancestral haplotype space in 1,887 commercially available outbred mice. We mapped 156 unique quantitative trait loci for 92 phenotypes at a 5% false discovery rate. Gene-level mapping resolution was achieved at about one-fifth of the loci, implicating Unc13c and Pgc1a at loci for the quality of sleep, Adarb2 for home cage activity, Rtkn2 for intensity of reaction to startle, Bmp2 for wound healing, Il15 and Id2 for several T cell measures and Prkca for bone mineral content. These findings have implications for diverse areas of mammalian biology and demonstrate how genome-wide association studies can be extended via low-coverage sequencing to species with highly recombinant outbred populations.

31 October 2008 in Medical Engineering & Physics
Verified
Journal Article
Closed access
JGJennifer S. Gregory
Jennifer S. Gregory
RARichard M. Aspden
Richard M. Aspden
Osteoporotic hip fracture is associated with high mortality and morbidity and often results in a loss of mobility and independence. Osteoporosis is diagnosed by measuring Bone Mineral Density (BMD), a measure of the amount of mineral in a bone. Although BMD continues to serve well it does not fully account for bone strength and only partially accounts for the risk of hip fracture. The shape and structure of the proximal femur also help to determine how forces act in the hip in a fall and their measurement can aid the prediction of hip fracture. This review examines the link between simple geometrical measures of the proximal femur and hip fracture, or bone strength. It will explore how they relate to each other and to anthropometric factors such as sex, height, weight and age. Limitations in these measures will be identified and new methods of analysis reviewed that encompass many different aspects of the shape of the femur. These new methods show great promise for improving the prediction of fracture risk in the future.

7 November 2003 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
JGJ. S. Gregory
J. S. Gregory
DTD. Testi
D. Testi
ASA. Stewart
A. Stewart
PUP. E. Undrill
P. E. Undrill
DRD. M. Reid
D. M. Reid
RAR. M. Aspden
R. M. Aspden

1 January 2021 in Therapeutic Advances in Musculoskeletal Disease
Verified
Journal Article
Open access
PDF file
VAVeena Aggarwal
Veena Aggarwal
CMChristina Maslen
Christina Maslen
RARichard L. Abel
Richard L. Abel
PBPinaki Bhattacharya
Pinaki Bhattacharya
PBPaul A Bromiley
Paul A Bromiley
KPKenneth E. S. Poole
Kenneth E. S. Poole
Osteoporosis causes bones to become weak, porous and fracture more easily. While a vertebral fracture is the archetypal fracture of osteoporosis, it is also the most difficult to diagnose clinically. Patients often suffer further spine or other fractures, deformity, height loss and pain before diagnosis. There were an estimated 520,000 fragility fractures in the United Kingdom (UK) in 2017 (costing £4.5 billion), a figure set to increase 30% by 2030. One way to improve both vertebral fracture identification and the diagnosis of osteoporosis is to assess a patient’s spine or hips during routine computed tomography (CT) scans. Patients attend routine CT for diagnosis and monitoring of various medical conditions, but the skeleton can be overlooked as radiologists concentrate on the primary reason for scanning. More than half a million CT scans done each year in the National Health Service (NHS) could potentially be screened for osteoporosis (increasing 5% annually). If CT-based screening became embedded in practice, then the technique could have a positive clinical impact in the identification of fragility fracture and/or low bone density. Several companies have developed software methods to diagnose osteoporosis/fragile bone strength and/or identify vertebral fractures in CT datasets, using various methods that include image processing, computational modelling, artificial intelligence and biomechanical engineering concepts. Technology to evaluate Hounsfield units is used to calculate bone density, but not necessarily bone strength. In this rapid evidence review, we summarise the current literature underpinning approved technologies for opportunistic screening of routine CT images to identify fractures, bone density or strength information. We highlight how other new software technologies have become embedded in NHS clinical practice (having overcome barriers to implementation) and highlight how the novel osteoporosis technologies could follow suit. We define the key unanswered questions where further research is needed to enable the adoption of these technologies for maximal patient benefit.

2 December 2011 in Rheumatology
Verified
Journal Article
Open access
PDF file
RBRebecca J. Barr
Rebecca J. Barr
JGJennifer S. Gregory
Jennifer S. Gregory
DRDavid M. Reid
David M. Reid
RARichard M. Aspden
Richard M. Aspden
KYKanako Yoshida
Kanako Yoshida
GMGary Macfarlane
Gary Macfarlane
Objective. Previously, active shape modelling (ASM) of the proximal femur was shown to identify those individuals at highest risk of developing radiographic OA. Here we determine whether ASM predicts the need for total hip replacement (THR) independent of Kellgren–Lawrence grade (KLG) and other known risk factors.